First Republic Investment Management, Inc. Fate Therapeutics Inc Call Options Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FATE
# of Institutions
166Shares Held
101MCall Options Held
41.3KPut Options Held
15.9K-
Redmile Group, LLC San Francisco, CA12.9MShares$19.7 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$15.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$15.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$7.4 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$6.7 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $148M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...